Researchers succeeded in detecting human antibodies have been installed in the laboratories were able to protect mice from lethal doses of different types of bird flu, including bird flu.
The researchers, who published their studies on a Sunday "Nachur Stractoral Land Molekolar biological," said the e-antibody, which comes from the identical cells that could be used for the prevention of influenza, or deal with them. The seasonal flu caused the deaths of more than 250 thousand people a year in the world.
After the injury, illness or vaccination, the body produces antibodies to prevent future exposure to the virus but do not generally affect only the type of virus that cause disease.
Succeeded and where Mrasko Professor at the Institute of Medicine at Harvard and his team in the detection of antibodies to resist the protein responsible for cell adhesion of influenza virus.
And the work of researchers at the tens of billions of synthetic antibodies, and 10 found effective against the four major species of bird flu (H5, 1). The three types of these antibodies have been tested on mice is effective against other types of influenza.
Said Anthony Fauci, director of the American Institute for infections and allergies of the National Institute of Health that "this promising discovery."
In his view, in the event of an outbreak of the virus, "antibodies may constitute an integral part of the human element of medicine countermeasures to contain the disease until a vaccine production."
The researchers now want to test the antibody on animals, the son of the ideal model for the lender flu. At a later stage to be developed for the medical version of an antibody that may lead to the development of a product over the years especially since the licensee was found that certain antibodies and effective.
The researchers, who published their studies on a Sunday "Nachur Stractoral Land Molekolar biological," said the e-antibody, which comes from the identical cells that could be used for the prevention of influenza, or deal with them. The seasonal flu caused the deaths of more than 250 thousand people a year in the world.
After the injury, illness or vaccination, the body produces antibodies to prevent future exposure to the virus but do not generally affect only the type of virus that cause disease.
Succeeded and where Mrasko Professor at the Institute of Medicine at Harvard and his team in the detection of antibodies to resist the protein responsible for cell adhesion of influenza virus.
And the work of researchers at the tens of billions of synthetic antibodies, and 10 found effective against the four major species of bird flu (H5, 1). The three types of these antibodies have been tested on mice is effective against other types of influenza.
Said Anthony Fauci, director of the American Institute for infections and allergies of the National Institute of Health that "this promising discovery."
In his view, in the event of an outbreak of the virus, "antibodies may constitute an integral part of the human element of medicine countermeasures to contain the disease until a vaccine production."
The researchers now want to test the antibody on animals, the son of the ideal model for the lender flu. At a later stage to be developed for the medical version of an antibody that may lead to the development of a product over the years especially since the licensee was found that certain antibodies and effective.
